Login
Powered by
MOMENTUM
MEDIA
Powered by MOMENTUM MEDIA
Gut health business Microba Life Sciences (ASX: MAP) has successfully listed on the Australian Securities Exchange, in an initial public offering that raised $30 million.
Firm: Thomson Geer (Microba Life Sciences)
The IPO was backed by New York Stock Exchange-listed synthetic biology company Ginkgo Bioworks, which is backed by Bill Gates.
Area: Corporate, M&A
Value: $30 million
Key players: The Thomson Geer team was led by partner Emma Cook, who was supported by Belinda Pinnow and Robin Mahly.
Deal significance: Ms Cook said: “We were pleased to have been able to help Microba list on the ASX and enable investors to support its work in human health.”
The Lawyers Weekly Jobs Board has had a refresh! To check out the latest opportunities in private practice, in-house and more, click here.
Jerome Doraisamy is the managing editor of Lawyers Weekly and HR Leader. He is also the author of The Wellness Doctrines book series, an admitted solicitor in New South Wales, and a board director of the Minds Count Foundation.
You can email Jerome at:
Get breaking news
Jerome Doraisamy
